Late Gastrointestinal and Hepatic Effects

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/978-3-319-16435-9_12
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

  2016cited by this paper
• Radiation-induced esophageal strictures in children with cancer

  2014cited by this paper
• Incidence, Risk Factors, and Outcome

  2014cited by this paper
• Cancer screening in the United States, 2013

  2013cited by this paper
• Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors.

  2013cited by this paper
• Second malignant neoplasms in digestive organs after childhood cancer: a cohort-nested case-control study.

  2012cited by this paper
• Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.

  2012cited by this paper
• Secondary Gastrointestinal Cancer in Childhood Cancer Survivors

  2012cited by this paper
• Secondary colorectal carcinoma after childhood cancer.

  2012cited by this paper
• Focal nodular hyperplasia in children, adolescents, and young adults

  2011cited by this paper
• Barrett esophagus in long-term survivors of childhood solid tumors.

  2011cited by this paper
• Long-term follow-up of children with 6-thioguanine-related chronic hepatoxicity following treatment for acute lymphoblastic leukaemia.

  2011cited by this paper
• The clinical course in pediatric solid tumor patients with focal nodular hyperplasia of the liver

  2011cited by this paper
• Variable MR imaging appearances of focal nodular hyperplasia in pediatric cancer patients

  2011cited by this paper
• Survivors of childhood cancer have increased risk of gastrointestinal complications later in life.

  2011cited by this paper
• Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

  2011cited by this paper
• Focal nodular hyperplasia or focal nodular hyperplasia‐like lesions of the liver: A special emphasis on diagnosis

  2011cited by this paper
• Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor?

  2011cited by this paper
• Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On

  2010cited by this paper
• Focal nodular hyperplasia in pediatric patients with and without oncologic history

  2010cited by this paper
• Knowledge of hepatitis C virus screening in long‐term pediatric cancer survivors

  2010cited by this paper
• Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma: how much diagnostic imaging is necessary?

  2010cited by this paper
• Gastrointestinal toxicity associated to radiation therapy.

  2010cited by this paper
• Late effects of abdominal irradiation in children: a review of the literature.

  2010cited by this paper
• Radiation dose-volume effects in the stomach and small bowel.

  2010cited by this paper
• Esophageal strictures during treatment for acute lymphoblastic leukemia.

  2010cited by this paper
• Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.

  2010cited by this paper
• Radiation-associated liver injury.

  2010cited by this paper
• An updated follow‐up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy

  2010cited by this paper
• Hepato‐biliary late effects in survivors of childhood and adolescent cancer: A report from the Children's Oncology Group

  2009cited by this paper
• Part II: Liver function in oncology: towards safer chemotherapy use.

  2008cited by this paper
• The thiopurine methyltransferase genetic polymorphism is associated with thioguanine‐related veno‐occlusive disease of the liver in children with acute lymphoblastic leukemia

  2006cited by this paper
• Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.

  2006cited by this paper
• Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

  2006cited by this paper
• The management of treatment-related esophageal complications in children and adolescents with cancer.

  2006cited by this paper
• Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors.

  2005cited by this paper
• Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6‐thioguanine during maintenance therapy

  2005cited by this paper
• American Cancer Society Guidelines for the Early Detection of Cancer, 2004

  2004cited by this paper
• Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.

  2004cited by this paper
• The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort.

  2004cited by this paper
• Chronic hepatotoxicity following 6‐thioguanine therapy for childhood acute lymphoblastic leukaemia

  2004cited by this paper
• Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy

  2004cited by this paper
• Pediatric Hodgkin's disease.

  2004cited by this paper
• Nodular regenerative hyperplasia of the liver simulating metastases following treatment for bilateral Wilms tumor.

  2003cited by this paper
• Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters.

  2003cited by this paper
• Hepatic focal nodular hyperplasia in children previously treated for a solid tumor

  2003cited by this paper
• High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.

  2003cited by this paper
• Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings.

  2003cited by this paper
• Hepatitis B and C Infection in Children Undergoing Chemotherapy or Bone Marrow Transplantation

  2003cited by this paper
• Hepatitis C infection during treatment for childhood cancer: pitfalls in diagnosis and management.

  2002cited by this paper
• End-stage liver disease in persons with hemophilia and transfusion-associated infections.

  2002cited by this paper
• Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome.

  2002cited by this paper
• Management of cholelithiasis in pediatric patients who undergo bone marrow transplantation.

  2001cited by this paper
• The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders.

  2001cited by this paper
• Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer.

  2001cited by this paper
• Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.

  2000cited by this paper
• Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C

  2000cited by this paper
• American Cancer Society guidelines for the early detection of cancer

  2000cited by this paper
• Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.

  2000cited by this paper
• Hepatic regenerating nodules: a mimic of recurrent cancer in children

  2000cited by this paper
• Focal nodular hyperplasia of the liver: Direct evidence of circulatory disturbances

  2000cited by this paper
• Chronic hepatitis C virus infections in leukemia survivors: Prevalence, viral load, and severity of liver disease

  1999cited by this paper
• Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

  1999cited by this paper
• Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

  1999cited by this paper
• Chronische Hepatopathien nach Behandlung maligner Erkrankungen bei Kindern

  1999cited by this paper
• Cirrhosis of the liver in long-term marrow transplant survivors.

  1999cited by this paper
• Long‐term follow‐up in hematopoieticstem‐cell transplant patients

  1999cited by this paper
• Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infection

  1999cited by this paper
• Late effects of treatment for germ cell tumors during childhood and adolescence.

  1999cited by this paper
• Biopsy Pathology of the Liver

  1998cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.

  1997cited by this paper
• Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation

  1997cited by this paper
• Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia

  1997cited by this paper
• Beta‐adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta‐analysis

  1997cited by this paper
• Chronic hepatitis C virus infection after treatment for pediatric malignancy.

  1997cited by this paper
• Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study.

  1997cited by this paper
• Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation.

  1996cited by this paper
• Chronic hepatitis C in long term survivors of haematological malignancy treated in a single centre.

  1996cited by this paper
• Liver function studies in children with acute lymphocytic leukemia after cessation of therapy.

  1994cited by this paper
• Paratesticular rhabdomyosarcoma: Delayed effects of multimodality therapy and implications for current management

  1994cited by this paper
• Long‐Term Complications of Laparotomy in Hodgkin's Disease

  1994cited by this paper
• Interferon for chronic hepatitis C in patients cured of malignancy

  1994cited by this paper
• Hepatitis C virus infection in children treated for acute lymphoblastic leukemia.

  1994cited by this paper
• Evidence against the role of hepatitis C virus in severe liver damage occurring early in the course of acute leukemia in children.

  1994cited by this paper
• Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH.

  1994cited by this paper
• Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients

  1993cited by this paper
• Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the intergroup rhabdomyosarcoma study committee

  1993cited by this paper
• Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy.

  1993cited by this paper
• High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.

  1992cited by this paper
• Surgical complications after nephrectomy for Wilms' tumor.

  1992cited by this paper
• Second malignancies in very-long-term survivors of childhood cancer.

  1992cited by this paper
• Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee.

  1992cited by this paper
• Chemotherapeutic agents and hepatotoxicity.

  1992cited by this paper
• Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation.

  1991cited by this paper
• Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

  1991cited by this paper
• Cholelithiasis after treatment for childhood cancer

  1991cited by this paper
• Hepatopathy-thrombocytopenia syndrome--a complication of dactinomycin therapy for Wilms' tumor: a report from the United Kingdom Childrens Cancer Study Group.

  1991cited by this paper
• Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission.

  1991cited by this paper
• Esophageal obstruction 14 years after treatment for Hodgkin's disease

  1991cited by this paper

• Risk of severe esophageal stricture among childhood cancer survivors – A population-based case-cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS)

  2024cites this paper
• Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group.

  2021cites this paper
• Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

  2019cites this paper
• Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors.

  2013cites this paper
• Optimization of care for survivors of childhood cancer

  2013influential citation